FTSE All-Share
|
5 548,22
|
-50,24
|
-0,90 %
|
Analysen zu FTSE All-Share-Werten
| 10.12.25 | Rio Tinto Hold | Deutsche Bank AG | |
| 10.12.25 | BAT Buy | Deutsche Bank AG | |
| 10.12.25 | Rio Tinto Overweight | JP Morgan Chase & Co. | |
| 10.12.25 | BAT Buy | Jefferies & Company Inc. | |
| 10.12.25 | Unilever Sell | UBS AG | |
| 09.12.25 | Unilever Underperform | Jefferies & Company Inc. | |
| 09.12.25 | GSK Underweight | JP Morgan Chase & Co. | |
| 09.12.25 | Unilever Outperform | Bernstein Research | |
| 09.12.25 | BAT Underperform | RBC Capital Markets | |
| 09.12.25 | BAT Overweight | Barclays Capital | |
| 09.12.25 | Unilever Overweight | Barclays Capital | |
| 09.12.25 | Unilever Underperform | RBC Capital Markets | |
| 09.12.25 | Rio Tinto Overweight | Barclays Capital | |
| 09.12.25 | BAT Neutral | JP Morgan Chase & Co. | |
| 09.12.25 | BAT Underperform | RBC Capital Markets | |
| 09.12.25 | BAT Buy | Jefferies & Company Inc. | |
| 09.12.25 | Rio Tinto Overweight | JP Morgan Chase & Co. | |
| 09.12.25 | Unilever Overweight | JP Morgan Chase & Co. | |
| 09.12.25 | London Stock Exchange Overweight | JP Morgan Chase & Co. | |
| 08.12.25 | Unilever Buy | Deutsche Bank AG | |
| 08.12.25 | Vodafone Group Overweight | Barclays Capital | |
| 08.12.25 | Rio Tinto Hold | Jefferies & Company Inc. | |
| 08.12.25 | GSK Underweight | JP Morgan Chase & Co. | |
| 08.12.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 05.12.25 | Unilever Underperform | Jefferies & Company Inc. | |
| 05.12.25 | Rio Tinto Buy | Goldman Sachs Group Inc. | |
| 05.12.25 | HSBC Holdings Sector Perform | RBC Capital Markets | |
| 05.12.25 | Rio Tinto Neutral | UBS AG | |
| 05.12.25 | Rio Tinto Hold | Deutsche Bank AG | |
| 05.12.25 | Diageo Hold | Deutsche Bank AG | |
| 05.12.25 | Shell Overweight | JP Morgan Chase & Co. | |
| 05.12.25 | BP Neutral | JP Morgan Chase & Co. | |
| 05.12.25 | National Grid Overweight | JP Morgan Chase & Co. | |
| 04.12.25 | Rio Tinto Overweight | Barclays Capital | |
| 04.12.25 | National Grid Overweight | Barclays Capital | |
| 04.12.25 | AstraZeneca Outperform | Bernstein Research | |
| 04.12.25 | BAT Buy | Jefferies & Company Inc. | |
| 04.12.25 | GSK Neutral | UBS AG | |
| 04.12.25 | Rio Tinto Sector Perform | RBC Capital Markets | |
| 04.12.25 | Diageo Neutral | UBS AG |
HOT STOCKS DER LETZTEN 3 TAGE
| Shell | 4 |
| London Stock Exchange | 3 |
| Vodafone Group | 3 |
| GSK | 3 |
| BAT | 1 |
| HSBC Holdings | 1 |
| BP | 1 |
Analysen zu Aktien folgender Indizes
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.